Using microarray gene expression network analyses, FLOT1 was also identified as a potential target regulated by core transcription factors related to the immunoreaction in nocturnal hemodialysis treatment in end stage renal disease patients49. This evidence concerns the gene FLOT1 and stage 5 chronic kidney disease.